Anders Erik Astrup Dahm

Author network for Anders Erik Astrup Dahm by COREMINE medical

Publications 2017

Dahm AE, Ghanima W (2017)
[No title available]
Tidsskr Nor Laegeforen, 137 (3), 171-172
PubMed 28181748

Publications 2016

Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
PLoS One, 11 (3), e0152114
PubMed 26999742

Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
J Thromb Haemost, 14 (2), 387-96
PubMed 26598923

Publications 2015

Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
J Thromb Haemost, 13 (3), 409-13
PubMed 25495894

Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
Thromb Haemost, 114 (5), 964-8
PubMed 26202881

Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE (2015)
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
Arterioscler Thromb Vasc Biol, 36 (2), 418-24
PubMed 26681757

Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
Spinal Cord, 53 (4), 285-90
PubMed 25644388

Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
PubMed 26258571

Publications 2014

Jacobsen EM, Dahm AE, Vartdal T, Sandset PM (2014)
[Anticoagulation for venous thrombosis and internal diseases]
Tidsskr Nor Laegeforen, 134 (9), 924
PubMed 24828715

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-34
PubMed 25180723

Kristiansen A, Brandt L, Berge E, Dahm AE, Halvorsen S, Sandset PM, Vandvik PO (2014)
[New guidelines for antithrombotic therapy and thromboprophylaxis]
Tidsskr Nor Laegeforen, 134 (9), 921-2
PubMed 24828713

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BMC Cancer, 14, 845
PubMed 25407022

Publications 2013

Dahm A (2013)
[A. Dahm replies]
Tidsskr Nor Laegeforen, 133 (16), 1687
PubMed 24005699

Dahm AE (2013)
[Estrogen supplements and research paradigms]
Tidsskr Nor Laegeforen, 133 (11), 1210-2
PubMed 23759784

Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Thromb Haemost, 109 (4), 606-13
PubMed 23407778

Publications 2012

Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
Thromb Haemost, 108 (6), 1165-71
PubMed 23015030

Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
Br J Haematol, 157 (6), 753-61
PubMed 22533697

Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
Thromb Res, 130 (1), 45-51
PubMed 22217510

Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
Mol Biol Rep, 39 (12), 10089-96
PubMed 22932941

Publications 2011

Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
Br J Haematol, 154 (2), 241-7
PubMed 21564075

Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
Blood Coagul Fibrinolysis, 22 (4), 254-9
PubMed 21297449

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
PubMed 21490090

Publications 2010

Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
J Thromb Haemost, 8 (5), 1130-2
PubMed 20149077

Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
J Thromb Haemost, 8 (11), 2443-9
PubMed 20735725

Publications 2009

Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
Mechanisms of thrombosis related to hormone therapy
Thromb Res, 123 Suppl 2, S70-3
PubMed 19217481

Publications 2007

Dahm AE, Sandset PM, Rosendaal FR (2007)
The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
J Thromb Haemost, 6 (2), 393-5
PubMed 18045239

van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2007)
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
J Thromb Haemost, 6 (2), 346-51
PubMed 18067603

Publications 2006

Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
J Thromb Haemost, 4 (8), 1840-2
PubMed 16879232

Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
Br J Haematol, 132 (3), 333-8
PubMed 16409298

Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
BMC Cardiovasc Disord, 6, 40
PubMed 17029634

Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
J Clin Oncol, 24 (17), 2683-4; author reply 2684
PubMed 16763285

Publications 2005

Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
J Thromb Haemost, 3 (4), 651-8
PubMed 15842349

Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2005)
Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
Thromb Res, 118 (2), 281-7
PubMed 16139333

de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
Determinants of the APTT- and ETP-based APC sensitivity tests
J Thromb Haemost, 3 (7), 1488-94
PubMed 15978106

Negaard H, Dahm A, Sandset PM, Iversen PO, Ostenstad B (2005)
Angiogenesis and hemostasis in hematological neoplasias
Curr. Drug Targets, 6 (6), 681-699

Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
Angiogenesis and hemostasis in hematological neoplasias
Curr Drug Targets, 6 (6), 683-99
PubMed 16178801

Publications 2003

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
Blood, 101 (11), 4387-92
PubMed 12560220

Publications 2002

Dahm AE, Brørs O (2002)
[Phenytoin poisoning caused by interaction with ticlopidine]
Tidsskr Nor Laegeforen, 122 (3), 278-80
PubMed 11894596

Publications 2000

Blomhoff S, Jacobsen MB, Spetalen S, Dahm A, Malt UF (2000)
Perceptual hyperreactivity to auditory stimuli in patients with irritable bowel syndrome
Scand J Gastroenterol, 35 (6), 583-9
PubMed 10912657